Ameeduzzafar zafar

Dr. Ameeduzzafar zafar

Department of Pharmaceutics, College of Pharmacy Jouf University, Al-Jouf, Saudi Arabia
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2022 in Gels
Verified
Journal Article
Open access
PDF file
Mohammad Javed AnsariMohammad Javed Ansari
Mohammad Javed Ansari
RRRahul R Rajendran
Rahul R Rajendran
SMSourav Mohanto
Sourav Mohanto
UAUnnati Agarwal
Unnati Agarwal
Kingshuk PandaKingshuk Panda
Kingshuk Panda
SPSheersha Pramanik
Sheersha Pramanik
A prominent research topic in contemporary advanced functional materials science is the production of smart materials based on polymers that may independently adjust their physical and/or chemical characteristics when subjected to external stimuli. Smart hydrogels based on poly(N-isopropylacrylamide) (PNIPAM) demonstrate distinct thermoresponsive features close to a lower critical solution temperature (LCST) that enhance their capability in various biomedical applications such as drug delivery, tissue engineering, and wound dressings. Nevertheless, they have intrinsic shortcomings such as poor mechanical properties, limited loading capacity of actives, and poor biodegradability. Formulation of PNIPAM with diverse functional constituents to develop hydrogel composites is an efficient scheme to overcome these defects, which can significantly help for practicable application. This review reports on the latest developments in functional PNIPAM-based smart hydrogels for various biomedical applications. The first section describes the properties of PNIPAM-based hydrogels, followed by potential applications in diverse fields. Ultimately, this review summarizes the challenges and opportunities in this emerging area of research and development concerning this fascinating polymer-based system deep-rooted in chemistry and material science.

1 March 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
Ameeduzzafar zafarAmeeduzzafar zafar
Ameeduzzafar zafar
Syed Sarim ImamSyed Sarim Imam
Syed Sarim Imam
Syed Nasir Abbas BukhariSyed Nasir Abbas Bukhari
Syed Nasir Abbas Bukhari
Javed AhmadJaved Ahmad
Javed Ahmad
AAAsgar Ali
Asgar Ali

1 September 2017 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
MQMohd Qumbar
Mohd Qumbar
Ameeduzzafar zafarAmeeduzzafar zafar
Ameeduzzafar zafar
Syed Sarim ImamSyed Sarim Imam
Syed Sarim Imam
JAJaved Ali
Javed Ali
Javed AhmadJaved Ahmad
Javed Ahmad
AAAsgar Ali
Asgar Ali

22 November 2021 in Polymers
Verified
Journal Article
Open access
PDF file
Syed Sarim ImamSyed Sarim Imam
Syed Sarim Imam
SASultan Alshehri
Sultan Alshehri
MGMohammed M. Ghoneim
Mohammed M. Ghoneim
Ameeduzzafar zafarAmeeduzzafar zafar
Ameeduzzafar zafar
OAOmar Awad Alsaidan
Omar Awad Alsaidan
RIRizwanullah
Rizwanullah
The excellent therapeutic potential of a variety of phytochemicals in different diseases has been proven by extensive studies throughout history. However, most phytochemicals are characterized by a high molecular weight, poor aqueous solubility, limited gastrointestinal permeability, extensive pre-systemic metabolism, and poor stability in the harsh gastrointestinal milieu. Therefore, loading of these phytochemicals in biodegradable and biocompatible nanoparticles (NPs) might be an effective approach to improve their bioactivity. Different nanocarrier systems have been developed in recent decades to deliver phytochemicals. Among them, NPs based on chitosan (CS) (CS-NPs), a mucoadhesive, non-toxic, and biodegradable polysaccharide, are considered the best nanoplatform for the oral delivery of phytochemicals. This review highlights the oral delivery of natural products, i.e., phytochemicals, encapsulated in NPs prepared from a natural polymer, i.e., CS, for improved bioavailability and bioactivity. The unique properties of CS for oral delivery such as its mucoadhesiveness, non-toxicity, excellent stability in the harsh environment of the GIT, good solubility in slightly acidic and alkaline conditions, and ability to enhance intestinal permeability are discussed first, and then the outcomes of various phytochemical-loaded CS-NPs after oral administration are discussed in detail. Furthermore, different challenges associated with the oral delivery of phytochemicals with CS-NPs and future directions are also discussed.

3 March 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MEMohammed Elkomy
Mohammed Elkomy
Nabil AlruwailiNabil Alruwaili
Nabil Alruwaili
MEMohammed Elmowafy
Mohammed Elmowafy
KSKhaled Shalaby
Khaled Shalaby
Ameeduzzafar zafarAmeeduzzafar zafar
Ameeduzzafar zafar
Hussein Mohammed EidHussein Mohammed Eid
Hussein Mohammed Eid
Rheumatoid arthritis (RA) is a chronic inflammatory illness affecting the joints. The characteristic of RA is gradual joint deterioration. Current RA treatment alleviates signs such as inflammation and pain and substantially slows the progression of the disease. In this study, we aimed to boost the transdermal delivery of berberine (a natural product) by encapsulating it in chitosan, surface-modified bilosomes nanogel for better management of the inflammation of RA. The chitosan-coated bilosomes loaded with berberine (BER-CTS-BLS) were formulated according to the thin-film hydration approach and optimized for various causal variables, considering the effect of lipid, sodium deoxycholate, and chitosan concentrations on the size of the particles, entrapment, and the surface charge. The optimized BER-CTS-BLS has 202.3 nm mean diameter, 83.8% entrapment, and 30.8 mV surface charge. The optimized BER-CTS-BLS exhibited a delayed-release profile in vitro and increased skin permeability ex vivo. Additionally, histological examination revealed that the formulated BLS had no irritating effects on the skin. Furthermore, the optimized BER-CTS-BLS ability to reduce inflammation was evaluated in rats with carrageenan-induced paw edema. Our results demonstrate that the group treated with topical BER-CTS-BLS gel exhibited a dramatic reduction in rat paw edema swelling percentage to reach 24.4% after 12 h, which was substantially lower than other groups. Collectively, chitosan-coated bilosomes containing berberine have emerged as a promising therapeutic approach to control RA inflammation.

29 May 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Syed Sarim ImamSyed Sarim Imam
Syed Sarim Imam
SASultan Alshehri
Sultan Alshehri
Mohammad AltamimiMohammad Altamimi
Mohammad Altamimi
Afzal HussainAfzal Hussain
Afzal Hussain
WQWajhul Qamar
Wajhul Qamar
BABjad K. Almutairy
Bjad K. Almutairy
The present research work is designed to prepare and evaluate piperine liposomes and piperine–chitosan-coated liposomes for oral delivery. Piperine (PPN) is a water-insoluble bioactive compound used for different diseases. The prepared formulations were evaluated for physicochemical study, mucoadhesive study, permeation study and in vitro cytotoxic study using the MCF7 breast cancer cell line. Piperine-loaded liposomes (PLF) were prepared by the thin-film evaporation method. The selected liposomes were coated with chitosan (PLFC) by electrostatic deposition to enhance the mucoadhesive property and in vitro therapeutic efficacy. Based on the findings of the study, the prepared PPN liposomes (PLF3) and chitosan coated PPN liposomes (PLF3C1) showed a nanometric size range of 165.7 ± 7.4 to 243.4 ± 7.5, a narrow polydispersity index (>0.3) and zeta potential (−7.1 to 29.8 mV). The average encapsulation efficiency was found to be between 60 and 80% for all prepared formulations. The drug release and permeation study profile showed biphasic release behavior and enhanced PPN permeation. The in vitro antioxidant study results showed a comparable antioxidant activity with pure PPN. The anticancer study depicted that the cell viability assay of tested PLF3C2 has significantly (p < 0.001)) reduced the IC50 when compared with pure PPN. The study revealed that oral chitosan-coated liposomes are a promising delivery system for the PPN and can increase the therapeutic efficacy against the breast cancer cell line.